77 results
424B5
VANI
Vivani Medical Inc
5 Mar 24
Prospectus supplement for primary offering
11:31am
to a wide range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease and eye injury. Orion is intended to convert images … are legally blind from eye trauma, optic nerve disease and injury, diabetic retinopathy, retinitis pigmentosa, age related macular degeneration, glaucoma
DEFR14A
VANI
Vivani Medical Inc
1 May 23
Revised proxy
4:49pm
a director’s duties is, or should be, aware of a risk of serious injury to the corporation or its stockholders;
(v) Acts or omissions
8-K
EX-10.1
odq zip725
28 Nov 22
Entry into a Material Definitive Agreement
5:29pm
S-8
u90fs
2 Sep 22
Registration of securities for employees
5:00pm
DEFA14A
h9u h6rbvmiqmp
18 Jul 22
Additional proxy soliciting materials
8:47am
425
EX-99.1
he6wo
18 Jul 22
Business combination disclosure
8:45am
8-K
EX-99.1
5nd6qeq3bktv42 7h
18 Jul 22
Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study
8:44am
DEFM14A
jdh1mbkoxydt qskw5
24 Jun 22
Proxy related to merger
4:44pm
424B3
5q4xi
24 Jun 22
Prospectus supplement
4:38pm
S-4/A
n8fabpc28ac1hx
16 Jun 22
Registration of securities issued in business combination transactions (amended)
5:23pm
S-4
ygjvdt
13 May 22
Registration of securities issued in business combination transactions
5:10pm
425
EX-99.1
4v18 q0mr5cnn10m
8 Feb 22
Business combination disclosure
12:00am